Summary We describe the creation, and the first 2 years experience, of the Gambian National Cancer Registry. The major problems involved in the creation of such a registry in a developing country are discussed. The data accumulated show a low overall rate of cancer incidence compared to more developed parts of the world and indicate that the prevalent cancers, hepatoma, carcinoma of the cervix and lymphoma, are likely to be due to infectious agents. It is hoped that immunisation of children under one year against hepatitis B will drastically reduce the incidence of hepatocellular carcinoma.
The Gambia National Cancer Registry has been created as part of the Gambia Hepatitis Intervention Study (GHIS). This study is designed to introduce hepatitis B vaccine into the national Expanded Programme of Immunization (EPI) in a phased manner to allow the evaluation of the protective effectiveness of the vaccine against chronic liver disease, specifically primary hepatocellular carcinoma. The design of this study (The Gambia Hepatitis Study Group, 1987) and of the integration of the vaccine into the EPI (The Gambia Hepatitis Study Group, 1989) are described in detail elsewhere. The outcome of this study is to be measured through cancer registration over the next 35 years. The Registry has been established from the beginning of the immunisation programme to allow validation of the assumptions made in the sample size estimates for the study. All cancers are registered although there is special emphasis on liver tumours.
Methods
The Gambia has three major tertiary care facilities; the Royal Victoria Hospital in Banjul, the inpatient ward at the Medical Research Council (MRC) laboratories in Fajara and, in the eastern part of the country, Bansang Hospital. In addition, there are doctors at five of the major health centres, at MRC field stations and at mission clinics (see Figure 1 ). Table I . Standardisation of rates was performed by the direct method using the standard 'world' population-widely used for cancer incidence standardisation (Waterhouse et al., 1982) .
Results
In the first 2 years of operation 559 patients suffering from cancer have been registered. The numbers of patients and crude rates per 100,000 per annum by sex and site are shown in Table II The only sites for which the number of diagnoses is sufficient to analyse by age are primary hepatocellular carcinoma and cervix uteri. The distribution of these tumours by age and sex is shown in Table IV , the rates again rising consistently with age. The rates of hepatocellular carcinoma in men are three times those in women.
The basis of the diagnosis for all registered tumours, and for hepatocellular carcinoma alone, is shown in Table V . The immunological test referred to is alpha-fetoprotein estimation and the clinical diagnoses included the use of ultrasound which was employed in 96% of the clinical diagnoses of liver cancer. Alpha-fetoprotein estimation has been shown to have a sensitivity and specificity of greater than 90% in the diagnosis of hepatocellular carcinoma when a cut-off of 400ngmlh' is used (Kew, 1975) . This is improved in the Sahelian region by the addition of ultrasound examination (Tortey et al., 1985) . The death registers in Banjul were the initial source of information for 2% of the cancers registered but in all but 14 cases further information was available from other records to confirm the diagnosis.
An age-standardised incidence ratio for liver cancer was calculated for each of the three health regions in the country. These are shown in Figure 1 . The ratio in the eastern part of the country, which is the furthest from the major health facilities, is lower than in the other two. The vast majority (96%) of liver cancers were diagnosed at either the Royal Victoria Hospital or the MRC Laboratories, both of which are at the western end of the country. If the residents in the Western Health Region of the country are considered alone, the crude liver cancer rates in Table IV [1987] [1988] (Bayo et al., 1990 The rates of liver cancer also vary between the three registries, as can be seen in Table VI, with the rates for males in the Bamako registry being considerably higher than elsewhere. The Bamako registry also has higher rates of cancer at a number of sites, notably cervix cancer, stomach cancer in both sexes and breast cancer. In contrast, the Dakar register shows similar rates at all these sites except cervical cancer. It seems most probable that this site is underascertained in The Gambia rather than this being a true difference in incidence.
The steady rise of all cancer rates with age in both sexes suggests that the method of age determination is not too inaccurate. The decline in rates at old ages probably represents underascertainment again as the elderly are less likely to make long journeys to seek health care and have less belief in 'Western' medicine than the younger generations.
The rates of liver cancer by age (Table IV) show a similar effect but are remarkable for the young age of many of the 'Includes ultrasound. bEstimates of alpha-fetoprotein. (Parkin et al., 1984) . Thus liver cancer constituted 16% of all cancers in males in Liberia (Sobo, 1982) compared to 53% in The Gambia.
The absence of an in-country histopathology service discourages clinicians from taking biopsies, particularly when the neoplasm is advanced and no treatment is available. The UK pathologists provide a valuable and rapid service, however, and allow the prompt treatment of those neoplasms for which treatment is available, such as lymphoma. The fact that only 20% of neoplasms are histologically confirmed (Table V) is mitigated to some extent by the availability of alpha-fetoprotein assay and ultrasound examination.
The low observed number of cases of liver cancer compared to the expectation in the Eastern region probably represents underascertainment rather than a true difference in disease incidence. Thus the figures for the Western region are probably more representative of the distribution of this cancer in The Gambia. The four areas of poor ascertainment -cervix cancer, old age, rural areas and histology -are the focus of efforts to improve the Registry over the next years. However, the Registry has already established that it is possible to have reasonable country-wide registration. It is hoped that the Registry may be integrated with the national AIDS programme to allow examination of time trends in neoplasms related to human immunodeficiency virus.
The data are remarkable for the low overall rate of cancer compared to more developed parts of the world (see Table  VI ) and that the major cancers -hepatoma, cervix and lymphoid -are likely to be due to infectious agents. Case-control studies have suggested that 80% of hepatocellular carcinoma in the Senegambian region is attributable to persistent hepatitis B infection. This opens the possibility of prevention and the Gambia Hepatitis Intervention Study, by immunising children under 1 year against hepatitis B, hopes to prevent the most frequent cancer in the country (The Gambia Hepatitis Study Group, 1987 , 1989 .
